Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Respiratory Disease Vaccine Market?
In recent times, there has been a slight increase in the size of the respiratory disease vaccine market. The market is projected to rise from $69.99 billion in 2024 to $70.9 billion in 2025, with a compound annual growth rate (CAGR) of 1.3%. The expansion during the historic term can be traced back to the escalating occurrences of respiratory diseases, amplified awareness about vaccination among the public, initiatives for public health, and the increased need for efficacious and more bearable vaccines.
What Growth Rate Is Forecasted for the Respiratory Disease Vaccine Market by 2029?
Anticipations point towards a progressive increase in the size of the respiratory disease vaccine market in the upcoming years. By 2029, it is projected to expand to a total value of $79.16 billion, experiencing a compound annual growth rate (CAGR) of 2.8%. The expansion in this forecasted timeframe is ascribed to factors such as an expanding elderly population, greater expenditure on healthcare, capital injection in vaccine development, and readiness for pandemics. Major patterns expected during this forecast period encompass the introduction of innovative vaccines, joint research endeavors, advancements in the development of vaccines, and drug approval.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12924&type=smp
Which Key Companies Are Shaping the Future of the Respiratory Disease Vaccine Market?
Major companies operating in the respiratory disease vaccine market are Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC, Sinovac Biotech Co. Ltd., Moderna Inc., BioNTech SE, CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Emergent BioSolutions Inc., Seqirus, Bio Farma, Dynavax Technologies Corporation, Hualan Biological Bacterin Co. Ltd., Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Biological E. Limited, CanSino Biologics Inc., Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Incepta Vaccine Ltd., Inovio Pharmaceuticals Inc., Ology Bioservices, VBI Vaccines Inc.
Which Factors Are Driving Demand in the Respiratory Disease Vaccine Industry?
The growing number of tuberculosis cases is anticipated to bolster the expansion of the respiratory disease vaccine market. Tuberculosis (TB), a respiratory ailment resulting from the bacterium Mycobacterium tuberculosis primarily affecting the lungs, can also cause complications in other systems and organs within the body. The escalating prevalence of tuberculosis may stimulate endeavors to formulate and disseminate vaccines for respiratory diseases to curtail the tuberculosis spread. For example, in November 2023, the Centers for Disease Control and Prevention, a US Government agency, revealed that there were 8,331 TB cases reported in the US in 2022, exhibiting a 5.9% surge in the case count compared to 2021. The incidence rate escalated to 2.5 cases per 100,000 individuals, depicting a 5.5% rise from the previous year. Thus, the rising incidence of tuberculosis is likely to fuel the growth of the respiratory disease vaccine market.
Respiratory Disease Vaccine Market Driver: Escalating Prevalence Of Smoking Fuels The Respiratory Disease Vaccine Market
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12924&type=smp
How Is the Respiratory Disease Vaccine Market Segmented by Several Divisions?
The respiratory disease vaccine market covered in this report is segmented –
1) By Type: Viral Vaccine, Bacterial Vaccine, Combination Vaccine
2) By Infection: COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections
3) By Age: Infant, Adolescent, Adult
4) By End-User: Clinic, Hospital, Other End-Users
Subsegments:
1) By Viral Vaccine: Influenza Vaccine, Respiratory Syncytial Virus (RSV) Vaccine, Coronavirus Vaccine
2) By Bacterial Vaccine: Pneumococcal Vaccine, Haemophilus Influenzae Type B (Hib) Vaccine, Pertussis Vaccine
3) By Combination Vaccine: DTaP With Hib And IPV, Pneumococcal Conjugate Vaccine With Influenza Vaccine, MMRV
What are the Emerging Market Trends Driving the Growth of the Respiratory Disease Vaccine Industry?
Leading enterprises in the respiratory disease vaccine market are focusing on product innovation to enhance their effectiveness and provide superior solutions for the prevention and treatment of respiratory disease infections. For instance, Pfizer Inc., a pharmaceutical corporation based in the United States, received approval from the Food and Drug Administration (FDA) in May 2023 for ABRYSVO (Respiratory Syncytial Virus Vaccine). This bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine is for preventing lower respiratory tract disease triggered by the respiratory syncytial virus in persons aged 60 and above. Comprising a pair of tailored preF proteins, ABRYSVO aims to boost immunity towards RSV A and B strains and has been clinically validated for safety and efficacy.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/respiratory-disease-vaccine-global-market-report
Which Regions Are Driving Growth in the Respiratory Disease Vaccine Market?
Asia-Pacific was the largest region in the respiratory disease vaccine market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory diseases vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12924
This Report Delivers Insight On:
1. How big is the respiratory disease vaccine market, and how is it changing globally?
2. Who are the major companies in the respiratory disease vaccine market, and how are they performing?
3. What are the key opportunities and risks in the respiratory disease vaccine market right now?
4. Which products or customer segments are growing the most in the respiratory disease vaccine market?
5. What factors are helping or slowing down the growth of the respiratory disease vaccine market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model